Cabaletta Bio (CABA) Current Assets (2018 - 2025)

Cabaletta Bio's Current Assets history runs 8 years deep, the most recent figure standing at $138.9 million for Q4 2025.

• On a quarterly basis, Current Assets fell 16.68% year-over-year to $138.9 million in Q4 2025; TTM through Dec 2025 was $138.9 million, a 16.68% decrease from a year earlier, with the FY2025 full-year figure at $138.9 million, down 16.68% from the prior year.
• Current Assets slipped to $138.9 million in Q4 2025 per CABA's latest filing, from $164.6 million in the prior quarter.
• Across five years, Current Assets topped out at $244.5 million in Q4 2023 and bottomed at $88.2 million in Q3 2022.
• The 5-year median for Current Assets is $136.7 million (2025), against an average of $148.5 million.
• Across the five-year window, Current Assets soared 137.62% in 2024 and sank 40.83% in 2025, its largest moves.
• Year by year, Current Assets stood at $124.5 million in 2021, then fell by 12.61% to $108.8 million in 2022, then soared by 124.64% to $244.5 million in 2023, then slumped by 31.83% to $166.7 million in 2024, then dropped by 16.68% to $138.9 million in 2025.
• Per Business Quant, the three latest CABA Current Assets figures stand at $138.9 million (Q4 2025), $164.6 million (Q3 2025), and $198.4 million (Q2 2025).